Ignite Creation Date:
2024-05-05 @ 9:13 PM
Last Modification Date:
2024-10-26 @ 10:01 AM
Study NCT ID:
NCT00837369
Status:
COMPLETED
Last Update Posted:
2012-07-23
First Post:
2009-02-03
Brief Title:
Regadenoson R-T Perfusion Imaging Trial
Sponsor:
University of Nebraska
Organization:
University of Nebraska
Study Overview
Official Title:
Regadenoson Real Time Perfusion Imaging Trial
Status:
COMPLETED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To exam the feasibility and accuracy of RTPE during vasodilator stress with 400micrograms of the A2A Receptor agonist Regadenoson for detection of significant coronary artery disease CAD in patients scheduled to undergo coronary angiography Sensitivity specificity and accuracy of perfusion and wall motion analysis to identify a coronary stenosis 50 in diameter by quantitive angiography will be analyzed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None